Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
1.710
+0.160 (10.32%)
At close: Oct 31, 2025, 4:00 PM EDT
1.650
-0.060 (-3.51%)
After-hours: Oct 31, 2025, 6:59 PM EDT
CNTB Revenue
Connect Biopharma Holdings had revenue of $48.00K in the quarter ending June 30, 2025, a decrease of -99.80%. This brings the company's revenue in the last twelve months to $1.97M, down -91.85% year-over-year. In the year 2024, Connect Biopharma Holdings had annual revenue of $26.03M.
Revenue (ttm)
$1.97M
Revenue Growth
-91.85%
P/S Ratio
48.17
Revenue / Employee
$31,694
Employees
62
Market Cap
95.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.03M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Jan 1, 2022 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| Eli Lilly and Company | 59.42B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
CNTB News
- 4 weeks ago - Connect Biopharma Presents Data Supporting Rademikibart at the European Respiratory Society Congress 2025 - GlobeNewsWire
- 2 months ago - Connect Biopharma Announces Two Presentations at the European Respiratory Society (ERS) Congress 2025 - GlobeNewsWire
- 2 months ago - Connect Biopharma Completes Termination of its American Depositary Receipt Program and Directly Lists its Ordinary Shares on Nasdaq - GlobeNewsWire
- 2 months ago - Connect Biopharma to Present at Two Upcoming Investor Conferences in September - GlobeNewsWire
- 2 months ago - Connect Biopharma Teams with Ickey Woods and the Jovante Woods Foundation to Expand Asthma Education Program Nationwide - GlobeNewsWire
- 2 months ago - Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors - GlobeNewsWire
- 3 months ago - Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq - GlobeNewsWire